PMID- 25625347 OWN - NLM STAT- MEDLINE DCOM- 20160304 LR - 20181113 IS - 1469-7793 (Electronic) IS - 0022-3751 (Print) IS - 0022-3751 (Linking) VI - 593 IP - 5 DP - 2015 Mar 1 TI - Corticosterone alters materno-fetal glucose partitioning and insulin signalling in pregnant mice. PG - 1307-21 LID - 10.1113/jphysiol.2014.287177 [doi] AB - Glucocorticoids affect glucose metabolism in adults and fetuses, although their effects on materno-fetal glucose partitioning remain unknown. The present study measured maternal hepatic glucose handling and placental glucose transport together with insulin signalling in these tissues in mice drinking corticosterone either from day (D) 11 to D16 or D14 to D19 of pregnancy (term = D21). On the final day of administration, corticosterone-treated mice were hyperinsulinaemic (P < 0.05) but normoglycaemic compared to untreated controls. In maternal liver, there was no change in glycogen content or glucose 6-phosphatase activity but increased Slc2a2 glucose transporter expression in corticosterone-treated mice, on D16 only (P < 0.05). On D19, but not D16, transplacental (3) H-methyl-d-glucose clearance was reduced by 33% in corticosterone-treated dams (P < 0.05). However, when corticosterone-treated animals were pair-fed to control intake, aiming to prevent the corticosterone-induced increase in food consumption, (3) H-methyl-d-glucose clearance was similar to the controls. Depending upon gestational age, corticosterone treatment increased phosphorylation of the insulin-signalling proteins, protein kinase B (Akt) and glycogen synthase-kinase 3beta, in maternal liver (P < 0.05) but not placenta (P > 0.05). Insulin receptor and insulin-like growth factor type I receptor abundance did not differ with treatment in either tissue. Corticosterone upregulated the stress-inducible mechanistic target of rapamycin (mTOR) suppressor, Redd1, in liver (D16 and D19) and placenta (D19), in ad libitum fed animals (P < 0.05). Concomitantly, hepatic protein content and placental weight were reduced on D19 (P < 0.05), in association with altered abundance and/or phosphorylation of signalling proteins downstream of mTOR. Taken together, the data indicate that maternal glucocorticoid excess reduces fetal growth partially by altering placental glucose transport and mTOR signalling. CI - (c) 2015 The Authors. The Journal of Physiology (c) 2015 The Physiological Society. FAU - Vaughan, O R AU - Vaughan OR AD - Centre for Trophoblast Research, Department of Physiology, Development and Neuroscience, University of Cambridge, Cambridge, CB2 3EG, UK. FAU - Fisher, H M AU - Fisher HM FAU - Dionelis, K N AU - Dionelis KN FAU - Jeffreys, E C AU - Jeffreys EC FAU - Higgins, J S AU - Higgins JS FAU - Musial, B AU - Musial B FAU - Sferruzzi-Perri, A N AU - Sferruzzi-Perri AN FAU - Fowden, A L AU - Fowden AL LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20150129 PL - England TA - J Physiol JT - The Journal of physiology JID - 0266262 RN - 0 (Anti-Inflammatory Agents) RN - 0 (Blood Glucose) RN - 0 (Ddit4 protein, mouse) RN - 0 (Insulin) RN - 0 (Transcription Factors) RN - 9005-79-2 (Glycogen) RN - EC 2.7.11.1 (Glycogen Synthase Kinase 3 beta) RN - EC 2.7.11.1 (Gsk3b protein, mouse) RN - EC 2.7.11.1 (Proto-Oncogene Proteins c-akt) RN - EC 2.7.11.26 (Glycogen Synthase Kinase 3) RN - W980KJ009P (Corticosterone) SB - IM EIN - J Physiol. 2016 Sep 1;594(17 ):5033. PMID: 27581573 MH - Animals MH - Anti-Inflammatory Agents/*pharmacology MH - Blood Glucose/*metabolism MH - Corticosterone/*pharmacology MH - Eating MH - Female MH - Fetal Blood/metabolism MH - Glycogen/metabolism MH - Glycogen Synthase Kinase 3/metabolism MH - Glycogen Synthase Kinase 3 beta MH - Insulin/blood/*metabolism MH - Liver/metabolism MH - Maternal-Fetal Exchange/*drug effects MH - Mice MH - Mice, Inbred C57BL MH - Placenta/metabolism MH - Pregnancy MH - Proto-Oncogene Proteins c-akt/metabolism MH - *Signal Transduction MH - Transcription Factors/genetics/metabolism PMC - PMC4358686 EDAT- 2015/01/28 06:00 MHDA- 2016/03/05 06:00 PMCR- 2016/03/01 CRDT- 2015/01/28 06:00 PHST- 2014/11/11 00:00 [received] PHST- 2014/12/24 00:00 [accepted] PHST- 2015/01/28 06:00 [entrez] PHST- 2015/01/28 06:00 [pubmed] PHST- 2016/03/05 06:00 [medline] PHST- 2016/03/01 00:00 [pmc-release] AID - 10.1113/jphysiol.2014.287177 [doi] PST - ppublish SO - J Physiol. 2015 Mar 1;593(5):1307-21. doi: 10.1113/jphysiol.2014.287177. Epub 2015 Jan 29.